Third quarter sales: KRW 1.1871 trillion, operating profit: KRW 338.6 billion Cumulative operating profit this year…
Tag:
Samsung Biologics
- Health
Samsung Biologics launches ‘S-Hycon’, a high-concentration formulation development platform… “Strengthening competitiveness in consignment development”
Samsung BioLogics participates in ‘Bio Japan 2024’ Securing ultra-high concentration (200mg/ml) formulation development technology and data…
2024-04-24 22:55:51 First quarter sales KRW 946.9 billion, operating profit KRW 221.3 billion The effects of…